ADXS stock news

The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 25.) Coherus Biosciences Inc (NASDAQ: CHRS ) The Medicines Company (NASDAQ: MDCO ) Down In The Dumps (Biotech stocks that hit 52-week lows Sept. 25.) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) Advaxis, Inc. (NASDAQ: ADXS ) AnaptysBio Inc (NASDAQ: ANAB ) Aridis Pharmaceuticals Inc (NASDAQ: ARDS ) AzurRx BioPharma Inc (NASDAQ: AZRX ) ( announced lackadaisical efficacy data for pancreatic insufficiency drug) BridgeBio Pharma Inc (NASDAQ: BBIO ) Calithera Biosciences Inc (NASDAQ: CALA ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Catalyst Biosciences Inc (NASDAQ: CBIO ) Cellectis SA (NASDAQ: CLLS ) CytomX Therapeutics Inc (NASDAQ: CTMX ) DelMar Pharmaceuticals Inc (NASDAQ: DMPI ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Exagen Inc (NASDAQ: XGN ) (IPOed on Sep. 16) Five Prime Therapeutics Inc (NASDAQ: FPRX ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Gemphire Therapeutics Inc (NASDAQ: GEMP ) Kalvista Pharmaceuticals Inc (NASDAQ: KALV ) Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA ) Myovant Sciences Ltd (NYSE: MYOV ) Neon Therapeutics Inc (NASDAQ: NTGN ) Novelion Therapeutics Inc (NASDAQ: NVLN ) Nuvectra Corp (NASDAQ: NVTR ) Onconova Therapeutics Inc (NASDAQ: ONTX ) PDS Biotechnology Corp (NASDAQ: PDSB ) Plus Therapeutics Inc (NASDAQ: PSTV ) Sarepta Therapeutics Inc (NASDAQ: SRPT ) Seelos Therapeutics Inc (NASDAQ: SEEL ) Sophiris Bio Inc (NASDAQ: SPHS ) Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH ) Stealth BioTherapeutics Corp (NASDAQ: MITO ) Surface Oncology Inc (NASDAQ: SURF ) Tocagen Inc (NASDAQ: TOCA ) Titan Pharmaceuticals, Inc. (NASDAQ: TTNP ) Urogen Pharma Ltd (NASDAQ: URGN ) Vaxart Inc (NASDAQ: VXRT ) (announced positive topline results for an early-stage … Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 24) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Celgene Corporation (NASDAQ: CELG ) Natera Inc (NASDAQ: NTRA ) Sanofi SA (NASDAQ: SNY ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL )(announced positive results for the pediatric Phase 3 trial of dasiglucagon for severe hypoglycemia in diabetes) Down In The Dumps (Biotech stocks hitting 52-week lows on Sept. 24) Aduro BioTech Inc (NASDAQ: ADRO ) Advaxis, Inc. (NASDAQ: ADXS ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Akcea Therapeutics Inc (NASDAQ: AKCA ) AnaptysBio Inc (NASDAQ: ANAB ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Citius Pharmaceuticals Inc (NASDAQ: CTXR ) Catalyst Biosciences Inc (NASDAQ: CBIO ) Cellectis SA (NASDAQ: CLLS ) Clovis Oncology Inc (NASDAQ: CLVS ) Crinetics Pharmaceuticals Inc (NASDAQ: CRNX ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Endologix, Inc. (NASDAQ: ELGX ) Erytech Pharma SA (NASDAQ: ERYP ) Five Prime Therapeutics Inc (NASDAQ: FPRX ) Fulcrum Therapeutics Inc (NASDAQ: FULC Innoviva Inc (NASDAQ: INVA ) Kalvista Pharmaceuticals Inc (NASDAQ: KALV ) Mersana Therapeutics Inc (NASDAQ: MRSN ) Myovant Sciences Ltd (NYSE: MYOV ) Neon Therapeutics Inc (NASDAQ: NTGN ) Onconova Therapeutics Inc (NASDAQ: ONTX ) ProQR Therapeutics NV (NASDAQ: PRQR ) Sarepta Therapeutics Inc (NASDAQ: SRPT ) Satsuma Pharmaceuticals Inc (NASDAQ: STSA ) (priced its IPO on Sept. 13) Seelos Therapeutics Inc (NASDAQ: … Read more
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Sept. 9.) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) ( reacted to positive Nuplazid data) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Protagonist Therapeutics Inc (NASDAQ: PTGX ) Scpharmaceuticals Inc (NASDAQ: SCPH ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Pfenex Inc (NYSE: PFNX ) Down In The Dumps (Biotech stocks that hit 52-week lows on Sept. 9.) Advaxis, Inc. (NASDAQ: ADXS ) (reacted to third-quarter results) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Endologix, Inc. (NASDAQ: ELGX ) Gemphire Therapeutics Inc (NASDAQ: GEMP ) Illumina, Inc. (NASDAQ: ILMN ) Neurotrope Inc (NASDAQ: NTRP ) ( Alzheimer's disease drug did not meet the primary endpoint) Obalon Therapeutics Inc (NASDAQ: OBLN ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Retrophin Inc (NASDAQ: RTRX ) Stealth BioTherapeutics Corp (NASDAQ: MITO ) Surface Oncology Inc (NASDAQ: SURF ) Trinity Biotech plc (NASDAQ: TRIB ) Transenterix Inc (NYSE: TRXC ) See also: Biotech Stock On The Radar: Ardelyx Gears Up For FDA Decision Day Stocks In Focus Translate Bio Discontinues Development Of mRNA Therapy Translate Bio Inc (NASDAQ: TBIO ) said in a clinical pipeline update that it has decided to discontinue the development of MRT5201, a liver-targeted treatment for ornithine transcarbamylase, or OTC, deficiency. Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 27) Castle Biosciences Inc (NASDAQ: CSTL ) The Medicines Company (NASDAQ: MDCO ) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 27) Abeona Therapeutics Inc (NASDAQ: ABEO ) Advaxis, Inc. (NASDAQ: ADXS ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Alder Biopharmaceuticals Inc (NASDAQ: ALDR ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alimera Sciences Inc (NASDAQ: ALIM ) AnaptysBio Inc (NASDAQ: ANAB ) ASLAN PHARMACEU/ADR (NASDAQ: ASLN ) Assembly Biosciences Inc (NASDAQ: ASMB ) Cancer Genetics Inc (NASDAQ: CGIX ) Catalyst Biosciences Inc (NASDAQ: CBIO ) Clearside Biomedical Inc (NASDAQ: CLSD ) Crinetics Pharmaceuticals Inc (NASDAQ: CRNX ) DelMar Pharmaceuticals Inc (NASDAQ: DMPI )(announced that its current cash position will be sufficient to complete enrollment in all three patient groups of its two ongoing Phase 2 trials for its lead compound VAL-083, which is likely to occur by the fourth quarter of 2020) ICU Medical, Incorporated (NASDAQ: ICUI ) Kala Pharmaceuticals Inc (NASDAQ: KALA ) Mallinckrodt PLC (NYSE: MNK )(reacted to an unfavorable ruling on a patent infringement lawsuit regarding its inhaled nitric oxide product) Neuralstem, Inc. (NASDAQ: CUR ) Novus Therapeutics Inc (NASDAQ: NVUS ) Obalon Therapeutics Inc (NASDAQ: OBLN ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Regenxbio Inc (NASDAQ: RGNX ) Revance Therapeutics Inc (NASDAQ: RVNC )(announced an amended agreement with Mylan NV (NASDAQ: MYL ), … Read more
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 26) DURECT Corporation (NASDAQ: DRRX ) Stoke Therapeutics Inc (NASDAQ: STOK ) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 26) Advaxis, Inc. (NASDAQ: ADXS ) Arbutus Biopharma Corp (NASDAQ: ABUS ) ASLAN PHARMACEU/ADR (NASDAQ: ASLN ) Avanos Medical Inc (NYSE: AVNS ) Cancer Genetics Inc (NASDAQ: CGIX ) Clearside Biomedical Inc (NASDAQ: CLSD ) Elanco Animal Health Inc (NYSE: ELAN )(Bank of America downgraded the shares to Neutral) Neurometrix Inc (NASDAQ: NURO ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Stealth BioTherapeutics Corp (NASDAQ: MITO ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) Tocagen Inc (NASDAQ: TOCA ) Unity Biotechnology Inc (NASDAQ: UBX ) Zafgen Inc (NASDAQ: ZFGN ) Stocks In Focus Nuvectra To Explore Strategic Options Nuvectra Corp (NASDAQ: NVTR ) announced its decision to explore strategic alternatives to … Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 12) GENMAB A/S/S ADR (NASDAQ: GMAB ) (IPOed July 1) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 13) Acer Therapeutics Inc (NASDAQ: ACER ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Adial Pharmaceuticals Inc (NASDAQ: ADIL ) Advaxis, Inc. (NASDAQ: ADXS ) AnaptysBio Inc (NASDAQ: ANAB ) Autolus Therapeutics Ltd – ADR (NASDAQ: AUTL ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Gamida Cell Ltd (NASDAQ: GMDA ) GENFIT S A/ADR (NASDAQ: GNFT ) Hemispherx BioPharma, Inc (NYSE: HEB ) Homology Medicines Inc (NASDAQ: FIXX ) INmune Bio Inc (NASDAQ: INMB )(reacted to second quarter results) Innovate Biopharmaceuticals Inc (NASDAQ: INNT ) Mallinckrodt PLC (NYSE: MNK )(was accused by Humana Inc (NYSE: HUM ) of manipulating prices of Achtar) Mersana Therapeutics Inc (NASDAQ: MRSN ) Novavax, Inc. (NASDAQ: NVAX )(reported new data from the Phase 3 trial dubbed PREPARE that evaluated its ResVax ) Obalon Therapeutics Inc (NASDAQ: OBLN ) Pfizer Inc. (NYSE: PFE ) Plus Therapeutics Inc (NASDAQ: PSTV ) Proteostasis … Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 29) Acasti Pharma Inc (NASDAQ: ACST ) Array Biopharma Inc (NASDAQ: ARRY ) GENMAB A/S/S ADR (NASDAQ: GMAB ) (IPOed July 18) Grifols SA - ADR ADR Class B (NASDAQ: GRFS ) Hologic, Inc. (NASDAQ: HOLX ) Novocure Ltd (NASDAQ: NVCR ) Odonate Therapeutics Inc (NASDAQ: ODT ) Repligen Corporation (NASDAQ: RGEN ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 29) Acer Therapeutics Inc (NASDAQ: ACER ) Advaxis, Inc. (NASDAQ: ADXS ) Cancer Genetics Inc (NASDAQ: CGIX ) Champions Oncology Inc (NASDAQ: CSBR ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Genprex Inc (NASDAQ: GNPX ) Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA ) Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX )(slumped in reaction to Sanofi SA (NASDAQ: SNY )'s decision to terminate their collaboration agreement regarding sotagliflozin that is being evaluated for Type 2 diabetes) Myovant Sciences Ltd (NYSE: MYOV ) Neovasc Inc (NASDAQ: NVCN ) Neon Therapeutics Inc (NASDAQ: NTGN ) Neuralstem, Inc. (NASDAQ: CUR ) Novavax, Inc. (NASDAQ: NVAX ) Oncolytics Biotech, Inc. (NASDAQ: ONCY ) Personalis Inc (NASDAQ: PSNL )( IPOed June 20) Cytori Therapeutics (NASDAQ: PSTV ) Proteostasis Therapeutics Inc (NASDAQ: PTI ) Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP ) TRACON Pharmaceuticals Inc (NASDAQ: TCON ) Unity Biotechnology Inc (NASDAQ: UBX ) Vistagen Therapeutics Inc (NASDAQ: VTGN ) Wave Life Sciences Ltd (NASDAQ: WVE ) (reacted … Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 23) Akero Therapeutics Inc (NASDAQ: AKRO ) Mirum Pharmaceuticals Inc (NASDAQ: MIRM )( IPOed June 18) Salarius Pharmaceuticals Inc (NASDAQ: SLRX ) VolitionRX Ltd (NYSE: VNRX ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 23) Abbott Laboratories (NYSE: ABT ) Abeona Therapeutics Inc (NASDAQ: ABEO ) Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) Advaxis, Inc. (NASDAQ: ADXS )(announced pricing of its 9.2 million common stock offering) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Apollo Endosurgery Inc (NASDAQ: APEN )(slipped ahead of earnings) Applied DNA Sciences Inc (NASDAQ: APDN ) Autolus Therapeutics Ltd – ADR (NASDAQ: AUTL ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM ) BIOLINERX LTD/S ADR (NASDAQ: BLRX ) Cancer Genetics Inc (NASDAQ: CGIX ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Foamix Pharmaceuticals Ltd (NASDAQ: FOMX ) Gamida Cell Ltd (NASDAQ: GMDA ) GENFIT S A/ADR (NASDAQ: GNFT ) Heat Biologics Inc (NASDAQ: HTBX ) HTG Molecular Diagnostics Inc (NASDAQ: HTGM ) Intra-Cellular Therapies Inc (NASDAQ: ITCI ) Invivo Therapeutics Holdings Corp (NASDAQ: NVIV ) Jaguar Health Inc (NASDAQ: JAGX ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Kindred Biosciences Inc (NASDAQ: KIN ) Marinus Pharmaceuticals Inc (NASDAQ: MRNS )( announced data from a late-stage study of postpartum depression drug) MEI Pharma Inc (NASDAQ: MEIP ) ) Myovant Sciences Ltd (NYSE: MYOV )(announced positive late-stage trial results for drug to treat uterine fibroids and heavy menstrual bleeding) Neon Therapeutics Inc (NASDAQ: NTGN ) Neovasc Inc (NASDAQ: NVCN ) Organogenesis Holdings Inc (NASDAQ: ORGO ) Psychemedics Corp. Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 8) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Inspire Medical Systems Inc (NYSE: INSP ) (announced UnitedHealth Group Inc (NYSE: UNH ) coverage for Inspire therapy for the treatment of obstructive sleep apnea) Sol Gel Technologies Ltd (NASDAQ: SLGL )( reported positive results for late-stage trials that evaluated its Epsolay microencapsulated benzoyl peroxide cream, 5%, in papulopustular rosacea. Down In The Dumps (Biotech stocks hitting 52-week lows on July 8) Advaxis, Inc. (NASDAQ: ADXS ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Evolent Health Inc (NYSE: EVH ) Foamix Pharmaceuticals Ltd (NASDAQ: FOMX ) Gamida Cell Ltd (NASDAQ: GMDA ) GENFIT S A/ADR (NASDAQ: GNFT ) Harvard Bioscience, Inc. (NASDAQ: HBIO )(announced departure of CEO Jeffrey Duchemin) Heat Biologics Inc (NASDAQ: HTBX ) Jaguar Health Inc (NASDAQ: JAGX ) Myovant Sciences Ltd (NYSE: MYOV ) Nuvectra Corp (NASDAQ: NVTR ) Puma Biotechnology Inc (NASDAQ: PBYI ) Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP ) TrovaGene Inc (NASDAQ: TROV ) See Also: Attention Biotech Investors: … Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 30) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Misonix, Inc. (NASDAQ: MSON ) Repligen Corporation (NASDAQ: RGEN ) Down In The Dumps (Biotech stocks hitting 52-week lows on May 30) Amneal Pharmaceuticals Inc (NYSE: AMRX ) Abeona Therapeutics Inc (NASDAQ: ABEO ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Advaxis, Inc. (NASDAQ: ADXS ) Alkermes Plc (NASDAQ: ALKS ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Emergent Biosolutions Inc (NYSE: EBS ) Fennec Pharmaceuticals Inc (NASDAQ: FENC ) Insys Therapeutics Inc (NASDAQ: INSY ) Minerva Neurosciences Inc (NASDAQ: NERV ) Mylan NV (NASDAQ: MYL ) Myovant Sciences Ltd (NYSE: MYOV )(announced $100 million worth of common stock offering) Neuronetics Inc (NASDAQ: STIM ) Seres Therapeutics Inc (NASDAQ: MCRB ) Teligent Inc (NASDAQ: TLGT ) Urogen Pharma Ltd (NASDAQ: URGN ) Teva Pharmaceutical Industries Ltd (NYSE: TEVA ) Theravance Biopharma Inc (NASDAQ: TBPH ) Zafgen Inc (NASDAQ: ZFGN ) ( reacted to safety concerns over its diabetes drug following the Type A meeting with FDA) Stock In Focus Merrimack Board Decides Against Sale Following Strategic Review Following the completion of a strategic review, Merrimack Pharmaceuticals Inc (NASDAQ: MACK ) said its board has decided to restructure the company such that its … Read more
Advaxis (ADXS) closed the most recent trading day at $3.29, moving -0.3% from the previous trading session. Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 2) Denali Therapeutics Inc (NASDAQ: DNLI ) Dr.Reddy's Laboratories Ltd (NYSE: RDY )(announced a settlement agreement with Celgene Corporation (NASDAQ: CELG ) regarding its ANDA related to generic Revlimid pending before Health Canada) Down In The Dumps (Biotech stocks hitting 52-week lows on April 2) Evoke Pharma Inc (NASDAQ: EVOK )(FDA issued a complete response letter for Gimoti, which is being evaluated for treating symptoms in adult women with acute and recurrent diabetic gastroparesis. Stock In Focus Advaxis To Offer Common Stock Advaxis, Inc. (NASDAQ: ADXS ), which rallied sharply Monday in reaction to clinical trial updates, announced its intention to offer its common stock in an underwritten public offering. The company said it intends to use the net proceeds to fund its R&D initiatives and for general corporate purposes. The stock slid 15.59 percent to $4.98 in after-hours trading. Read more

Proudly made at

ROCKIT